Clinical Researcher—June 2020 (Volume 34, Issue 6) FORM & FUNCTION Gary W. Cramer We’ve tackled the topic before in the ACRP Blog of how the repurposing of existing drugs […]
The present-day disruptions of the coronavirus pandemic on the clinical research enterprise can and will be addressed by stakeholders in ways that should deliver long-term benefits to both clinical trial […]
Clinical research professionals in search of work will need to be more flexible than ever, even as leaders at sponsors, contract research organizations (CROs), and sites will want to think […]
The U.S. Food and Drug Administration (FDA) is offering its FDA MyStudies app to investigators as a free platform to obtain informed consent securely from patients for eligible clinical trials […]
PAID MESSAGE The COVID-19 pandemic is a challenge that is forcing us to reexamine how we do pretty much everything. There is no roadmap—just a barrage of mutable information. […]